NIV Application in the Treatment of Asthmatic Children (NCT02939625) | Clinical Trial Compass
CompletedNot Applicable
NIV Application in the Treatment of Asthmatic Children
Brazil68 participantsStarted 2015-01
Plain-language summary
Asthma is characterized by recurrent episodes of bronchospasm, bronchial hyperresponsiveness and chronic airway inflammation and pharmacological treatment for this condition is done with bronchodilators and anti-inflammatory.
Who can participate
Age range5 Years – 11 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 5:11 years;
* Both sexes;
* Do not be included in any regular physical activity program;
* Having a diagnosis of asthma, according to the Global Initiative for Asthma (GINA);
* Not having received Theophylline or aminophylline and oral corticosteroids in the last 30 days;
* not have presented respiratory infection in the last two months;
* Signature of IC
Exclusion Criteria:
* Have done inhaled bronchodilator in less than 12 hours before the assessment;
* Inability to understand or perform any of the tests, due to physical and mental limitations;
* Intolerance proposed activities;
* Have heart disease inflammatory, congenital or ischemic origin;
* Being in the presence of any infectious process with fever.